Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB).

NCT03935841 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT03935841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03935841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB).
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Completed
Start date
June 7, 2019
Completion date
March 1, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, incretin effect, ketosis